Health
Double antibody against SARS-CoV-2 prevents therapy-resistant variants – Medical Xpress
An international consortium that includes researchers at Karolinska Institutet has developed a double antibody that targets two sites of the SARS-CoV-2 virus, thereby…
An international consortium that includes researchers at Karolinska Institutet has developed a double antibody that targets two sites of the SARS-CoV-2 virus, thereby preventing the virus from mutating to resist the therapy. A study published in the scientific journal Nature shows that the antibody potently neutralizes SARS-CoV-2 and its variants and protects against COVID-19 in mice.
Antibody-based immunotherapy has already been shown to be effective against COVID-19 but faces two main obstacles;…
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Noosa News21 hours agoE-biker charged with riding dangerously, assaulting cop
-
General20 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands